Loading... Please wait... Loading... Please wait...
ESTIMATED
05/09/2024
05/09/2024
(AS OF MARCH 31)
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 1 | -$0.14 | -$0.14 | -$0.14 |
| Q2 2024 | 4 | -$0.15 | -$0.13 | -$0.14 |
| Q3 2024 | 1 | -$0.13 | -$0.13 | -$0.13 |
| Q4 2024 | 1 | -$0.14 | -$0.14 | -$0.14 |
| Q1 2025 | 2 | -$0.12 | -$0.12 | -$0.12 |
| Q2 2025 | 2 | -$0.13 | -$0.13 | -$0.13 |
| Q3 2025 | 2 | -$0.15 | -$0.15 | -$0.15 |
| Q4 2025 | 2 | -$0.18 | -$0.18 | -$0.18 |
Clearside Biomedical, Inc. last posted its earnings results on Thursday, May 9th, 2024. The company reported $-0.17 earnings per share for the quarter, missing analysts' consensus estimates of $-0.14 by $0.03. The company had revenue of 230,000 for the quarter and had revenue of 8.23 M for the year. Clearside Biomedical, Inc. has generated $-1 earnings per share over the last year ($-0.53 diluted earnings per share) and currently has a price-to-earnings ratio of -2.54. Clearside Biomedical, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, August 12th, 2024 based on prior year's report dates.
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue | 05/10/2024 | Q1 2024 | -$0.17 | $585,000 | $230,000 | 03/12/2024 | Q4 2023 | -$0.10 | -$0.08 | 0.02 | $4.43 M | $6.35 M | 11/13/2023 | Q3 2023 | -$0.16 | -$0.15 | 0.01 | $859,000 | 08/14/2023 | Q2 2023 | -$0.14 | -$0.15 | -0.01 | $1.02 M | 05/12/2023 | Q1 2023 | -$0.21 | $144,000 | $4,000 | 03/14/2023 | Q4 2022 | -$0.14 | $100,000 | $330,000 | 11/09/2022 | Q3 2022 | -$0.03 | -$0.15 | -0.12 | $266,000 | 08/12/2022 | Q2 2022 | -$0.13 | $384,000 | 05/12/2022 | Q1 2022 | -$0.13 | $347,000 | 03/11/2022 | Q4 2021 | $0.31 | $16.33 M | $25.69 M | 11/10/2021 | Q3 2021 | -$0.09 | -$0.08 | 0.01 | $2.58 M | $3.07 M | 08/10/2021 | Q2 2021 | -$0.12 | -$0.11 | 0.01 | $586,500 | $780,000 | 05/17/2021 | Q1 2021 | -$0.08 | -$0.13 | -0.05 | $34,000 | 03/15/2021 | Q4 2020 | -$0.14 | $1.60 M | $11,000 | 11/10/2020 | Q3 2020 | -$0.14 | -$0.05 | 0.09 | $1.82 M | $3.43 M | 08/10/2020 | Q2 2020 | -$0.13 | -$0.13 | 0 | $2.33 M | $354,000 | 05/08/2020 | Q1 2020 | -$0.09 | -$0.07 | 0.03 | $4.10 M | 03/13/2020 | Q4 2019 | -$0.07 | $6.10 M | $1.94 M | 11/08/2019 | Q3 2019 | -$0.17 | $30,000 | $141,000 | 08/08/2019 | Q2 2019 | -$0.15 | $9,000 | $45,000 |
|---|
A. Clearside Biomedical, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, August 12th, 2024 based off last year's report dates.
A. The conference call for Clearside Biomedical, Inc.'s latest earnings report can be listened to online.
A. The conference call transcript for Clearside Biomedical, Inc.'s latest earnings report can be read online.
A. Clearside Biomedical, Inc. (NASDAQ:CLSD) has a recorded annual revenue of $8.23 M.
A. Clearside Biomedical, Inc. (NASDAQ:CLSD) has a recorded net income of $8.23 M. Clearside Biomedical, Inc. has generated $-0.53 earnings per share over the last four quarters.
A. Clearside Biomedical, Inc. (NASDAQ:CLSD) has a price-to-earnings ratio of -2.54 and price/earnings-to-growth ratio is -0.36.
